Health care costs and resource use were higher for patients with immunoglobulin A nephropathy who were at high-risk proteinuria and had decline in kidney function, newly published data show. Researchers led by Edgar V. Lerma, MD, clinical professor of medicine in nephrology at the University of Illinois, conducted a retrospective cohort study to offer current evidence on the epidemiology and